Literature DB >> 33157120

Melatonin Alters Fluid Phase Coexistence in POPC/DPPC/Cholesterol Membranes.

Nanqin Mei1, Morgan Robinson2, James H Davis3, Zoya Leonenko4.   

Abstract

The structure and biophysical properties of lipid membranes are important for cellular functions in health and disease. In Alzheimer's disease, the neuronal membrane is a target for toxic amyloid-β (Aβ). Melatonin is an important pineal gland hormone that has been shown to protect against Aβ toxicity in cellular and animal studies, but the molecular mechanism of this protection is not fully understood. Melatonin is a small membrane-active molecule that has been shown to interact with model lipid membranes and alter the membrane biophysical properties, such as membrane molecular order and dynamics. This effect of melatonin has been previously studied in simple model bilayers with one or two lipid components. To make it more relevant to neuronal membranes, we used a more complex ternary lipid mixture as our membrane model. In this study, we used 2H-NMR to investigate the effect of melatonin on the phase behavior of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and cholesterol lipid membranes. We used deuterium-labeled POPC-d31 and DPPC-d62,separately to probe the changes in hydrocarbon chain order as a function of temperature and melatonin concentration. We find that POPC/DPPC/cholesterol at molar proportions of 3:3:2 is close to liquid-disordered/liquid-ordered phase separation and that melatonin can induce phase separation in these ternary mixtures by preferentially incorporating into the disordered phase and increasing its level of disorder. At 5 mol% melatonin, we observed phase separation in samples with POPC-d31, but not with DPPC-d62, whereas at 10 mol% melatonin, phase separation was observed in both samples with either POPC-d31 or DPPC-d62. These results indicate that melatonin can have a strong effect on membrane structure and physical properties, which may provide some clues to understanding how melatonin protects against Aβ, and that choice of chain perdeuteration is an important consideration from a technical point of view.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33157120      PMCID: PMC7822731          DOI: 10.1016/j.bpj.2020.10.030

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  53 in total

1.  Melatonin directly interacts with cholesterol and alleviates cholesterol effects in dipalmitoylphosphatidylcholine monolayers.

Authors:  Youngjik Choi; Simon J Attwood; Matthew I Hoopes; Elizabeth Drolle; Mikko Karttunen; Zoya Leonenko
Journal:  Soft Matter       Date:  2014-01-07       Impact factor: 3.679

2.  Fluid phase lipid areas and bilayer thicknesses of commonly used phosphatidylcholines as a function of temperature.

Authors:  Norbert Kučerka; Mu-Ping Nieh; John Katsaras
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity.

Authors:  Gintaras Valincius; Frank Heinrich; Rima Budvytyte; David J Vanderah; Duncan J McGillivray; Yuri Sokolov; James E Hall; Mathias Lösche
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

Review 4.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

5.  Deciphering Melatonin-Stabilized Phase Separation in Phospholipid Bilayers.

Authors:  Dima Bolmatov; William T McClintic; Graham Taylor; Christopher B Stanley; Changwoo Do; C Patrick Collier; Zoya Leonenko; Maxim O Lavrentovich; John Katsaras
Journal:  Langmuir       Date:  2019-09-09       Impact factor: 3.882

6.  Bilayer thickness mismatch controls domain size in model membranes.

Authors:  Frederick A Heberle; Robin S Petruzielo; Jianjun Pan; Paul Drazba; Norbert Kučerka; Robert F Standaert; Gerald W Feigenson; John Katsaras
Journal:  J Am Chem Soc       Date:  2013-02-22       Impact factor: 15.419

7.  Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.

Authors:  Tahir Ali; Myeong Ok Kim
Journal:  J Pineal Res       Date:  2015-05-12       Impact factor: 13.007

8.  The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.

Authors:  Miguel A Pappolla; Marcia J Simovich; Tara Bryant-Thomas; Yau-Jan Chyan; Burkhard Poeggeler; Margarita Dubocovich; Roger Bick; George Perry; Felix Cruz-Sanchez; Mark A Smith
Journal:  J Pineal Res       Date:  2002-04       Impact factor: 13.007

9.  Phase studies of model biomembranes: macroscopic coexistence of Lalpha+Lbeta, with light-induced coexistence of Lalpha+Lo Phases.

Authors:  Jiang Zhao; Jing Wu; Huilin Shao; Fanrong Kong; Nieraj Jain; Geoffrey Hunt; Gerald Feigenson
Journal:  Biochim Biophys Acta       Date:  2007-07-25

10.  Membrane cholesterol content plays a key role in the neurotoxicity of β-amyloid: implications for Alzheimer's disease.

Authors:  Andrey Y Abramov; Maksim Ionov; Evgeny Pavlov; Michael R Duchen
Journal:  Aging Cell       Date:  2011-04-11       Impact factor: 9.304

View more
  1 in total

Review 1.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.